Rooney Tessa, Sharpe Louise, Todd Jemma, Tang Biya, Colagiuri Ben
School of Psychology, University of Sydney.
Health Psychol. 2024 Jan;43(1):41-57. doi: 10.1037/hea0001326. Epub 2023 Oct 16.
The nocebo effect represents a growing concern in clinical settings. Nocebo effects occur when the treatment context generates negative expectancies that trigger the experience or worsening of negative symptoms beyond any effects attributable to the treatment itself. Despite being identified in a range of outcomes and conditions, from pain to Parkinson's disease, there has not been an attempt to systematically quantify the nocebo effects across health outcomes. The purpose of the present review was thus to systematically review and meta-analyze the nocebo literature to quantify the size of the nocebo effect across outcomes and examine which factors moderate the size of the nocebo effect, including process of induction, treatment type, or health outcome.
Systematic searches of PubMed, PychInfo, Medline, and Web of Science identified 130 ( = 8,219) independent eligible studies. To be included, studies had to include both a nocebo and control group/condition, which were compared to isolate the nocebo effect size.
Overall, the magnitude of the nocebo effect was medium ( = 0.522) and highly heterogeneous. Two key moderators emerged: health outcome and process of induction. Here, the nocebo effect was medium for most somatic outcomes and affect, with no significant effect on worsening cognitive performance. Further, inducing nocebo effects through instruction in combination with conditioning produced larger nocebo effects.
The present review suggests nocebo effects can be reliably induced across somatic health outcomes, and interventions that target the effect of instructions will be of critical importance to reducing the occurrence of nocebo effects. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
在临床环境中,反安慰剂效应引发了越来越多的关注。当治疗背景产生负面预期,进而引发负面症状的体验或恶化,且这种恶化超出治疗本身的任何效果时,就会出现反安慰剂效应。尽管在从疼痛到帕金森病等一系列结果和病症中都发现了反安慰剂效应,但尚未有人尝试系统地量化不同健康结果中的反安慰剂效应。因此,本综述的目的是系统地回顾和荟萃分析反安慰剂效应的文献,以量化不同结果中反安慰剂效应的大小,并研究哪些因素会调节反安慰剂效应的大小,包括诱导过程、治疗类型或健康结果。
通过对PubMed、PychInfo、Medline和科学网进行系统检索,确定了130项(n = 8219)独立的符合条件的研究。要纳入研究,必须同时包括一个反安慰剂组和对照组/条件组,通过比较来分离反安慰剂效应的大小。
总体而言,反安慰剂效应的大小为中等(g = 0.522),且异质性很高。出现了两个关键的调节因素:健康结果和诱导过程。在这方面,对于大多数躯体结果和情感而言,反安慰剂效应为中等,对认知能力恶化没有显著影响。此外,通过指令结合条件作用诱导反安慰剂效应会产生更大的反安慰剂效应。
本综述表明,反安慰剂效应可以在躯体健康结果中可靠地诱导出来,针对指令效果的干预措施对于减少反安慰剂效应的发生至关重要。(PsycInfo数据库记录(c)2023美国心理学会,保留所有权利)